Adjuvant treatment for head and neck cancer in solid organ transplant recipients

Oral Oncol. 2015 May;51(5):e23-5. doi: 10.1016/j.oraloncology.2015.02.004. Epub 2015 Mar 6.

Authors

Naomi Rabinovics¹, Tuvia Hadar², Aviram Mizrachi², Gideon Bachar², Ofer Purim³, Aron Popovtzer³

Affiliations

¹ Department of Otorhinolaryngology Head and Neck Surgery, Tel Aviv University, Tel Aviv, Israel. Electronic address: naomirab@gmail.com.
² Department of Otorhinolaryngology Head and Neck Surgery, Tel Aviv University, Tel Aviv, Israel.
³ Department of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

PMID: 25753559
DOI: 10.1016/j.oraloncology.2015.02.004

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Carcinoma, Squamous Cell / drug therapy*
Chemotherapy, Adjuvant
Female
Head and Neck Neoplasms / drug therapy*
Humans
Male
Middle Aged
Organ Transplantation*
Young Adult